Tenaxis Medical, Inc. Announces Completion Of The Enrollment Phase Of Their Pivotal Study
Tenaxis Medical has completed enrollment of its pivotal US study for the ArterX Vascular Sealant™. The study was designed to enroll up
to 220 patients who were scheduled to receive a synthetic vascular graft or patch at 12 investigational sites within the US…
Related Articles
No related posts
No related posts
No comments yet. Be the first.
Leave a reply
